A year of research dominated by the coronavirus,

A very exciting, even “practice-changing,” clinical trial evaluated the immunotherapy drug avelumab for patients with advanced urothelial cancer …, A very exciting, even “practice-changing,” clinical trial evaluated the immunotherapy drug avelumab for patients with advanced urothelial cancer …, Read More